This study will involve:
At the first visit, baseline measures will be assessed and information about the study will be given. During the first week of the study data about your sleep and general health will be collected. At visit 2 you will be randomly assigned to either the active medication, placebo or a no-treatment condition, followed by another week of data assessment and a last visit.
You will be reimbursed for the costs associated with participating.
Ethics committee approval number: 2018/107
You may be eligible to participate in this study if you are:
Unfortunately, we have to exclude individuals who:
Please note that the capsules themselves are made of gelatine and therefore are not halal or vegan.
If you are interested in assisting with this important and exciting area of research, please contact the study facilitator Christoph Werner via email for more information.